Chartwell Investment Partners LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,694 shares of the medical equipment provider’s stock after acquiring an additional 229 shares during the quarter. Chartwell Investment Partners LLC’s holdings in Intuitive Surgical were worth $4,954,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently bought and sold shares of the company. Stanley Laman Group Ltd. bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $330,000. Ellevest Inc. boosted its holdings in shares of Intuitive Surgical by 76.7% during the 2nd quarter. Ellevest Inc. now owns 265 shares of the medical equipment provider’s stock worth $151,000 after buying an additional 115 shares in the last quarter. State of Alaska Department of Revenue grew its position in shares of Intuitive Surgical by 20.3% during the 2nd quarter. State of Alaska Department of Revenue now owns 23,952 shares of the medical equipment provider’s stock worth $13,648,000 after buying an additional 4,037 shares during the period. MERIAN GLOBAL INVESTORS UK Ltd bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $228,000. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of Intuitive Surgical by 32.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 11,024 shares of the medical equipment provider’s stock valued at $5,459,000 after acquiring an additional 2,695 shares during the period. 87.24% of the stock is currently owned by institutional investors.
NASDAQ:ISRG opened at $685.44 on Friday. The company has a market capitalization of $80.21 billion, a price-to-earnings ratio of 72.08, a PEG ratio of 11.93 and a beta of 0.93. The business has a 50 day moving average of $601.51 and a 200 day moving average of $554.82. Intuitive Surgical, Inc. has a 1-year low of $360.50 and a 1-year high of $704.00.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 21st. The medical equipment provider reported $1.11 EPS for the quarter, topping the consensus estimate of $0.59 by $0.52. Intuitive Surgical had a net margin of 26.07% and a return on equity of 13.62%. The firm had revenue of $852.10 million for the quarter, compared to the consensus estimate of $675.15 million. During the same period last year, the firm posted $3.25 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 7.17 EPS for the current fiscal year.
In other news, CFO Marshall Mohr sold 7,500 shares of the business’s stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $677.19, for a total value of $5,078,925.00. Following the completion of the sale, the chief financial officer now owns 22,172 shares of the company’s stock, valued at approximately $15,014,656.68. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Robert Desantis sold 1,798 shares of the stock in a transaction dated Friday, July 24th. The shares were sold at an average price of $666.21, for a total value of $1,197,845.58. Following the sale, the vice president now owns 3,348 shares of the company’s stock, valued at $2,230,471.08. The disclosure for this sale can be found here. Insiders sold 35,515 shares of company stock valued at $21,147,697 over the last three months. 1.60% of the stock is currently owned by insiders.
Several equities research analysts have weighed in on the stock. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $600.00 to $700.00 and gave the company an “overweight” rating in a research note on Wednesday, July 22nd. Piper Sandler raised their target price on Intuitive Surgical from $510.00 to $595.00 and gave the company a “neutral” rating in a research note on Wednesday, July 22nd. They noted that the move was a valuation call. Canaccord Genuity upped their price target on Intuitive Surgical from $562.00 to $725.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. BidaskClub raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Friday, July 17th. Finally, Stifel Nicolaus boosted their price objective on Intuitive Surgical from $575.00 to $715.00 and gave the company a “buy” rating in a report on Monday, July 20th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $660.67.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: Float
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.